Based on the key indicators related to Know Labs' liquidity, profitability, solvency, and operating efficiency, Know Labs may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. At this time, Know Labs' Total Current Assets are fairly stable compared to the past year. Other Current Liabilities is likely to climb to about 377.2 M in 2024, despite the fact that Net Debt is likely to grow to (4.4 M). Key indicators impacting Know Labs' financial strength include:
The financial analysis of Know Labs is a critical element in measuring its lifeblood. Investors should not minimize Know Labs' ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.
Cash And Equivalents
15.21 Million
Know
Select Account or Indicator
Market Cap
Enterprise Value
Price To Sales Ratio
Ptb Ratio
Days Sales Outstanding
Book Value Per Share
Free Cash Flow Yield
Operating Cash Flow Per Share
Average Payables
Stock Based Compensation To Revenue
Capex To Depreciation
Pb Ratio
Ev To Sales
Free Cash Flow Per Share
Roic
Inventory Turnover
Net Income Per Share
Days Of Inventory On Hand
Payables Turnover
Average Inventory
Research And Ddevelopement To Revenue
Capex To Revenue
Cash Per Share
Pocfratio
Interest Coverage
Capex To Operating Cash Flow
Pfcf Ratio
Days Payables Outstanding
Income Quality
Roe
Ev To Operating Cash Flow
Pe Ratio
Return On Tangible Assets
Ev To Free Cash Flow
Earnings Yield
Intangibles To Total Assets
Net Debt To E B I T D A
Current Ratio
Tangible Book Value Per Share
Receivables Turnover
Graham Number
Shareholders Equity Per Share
Debt To Equity
Capex Per Share
Graham Net Net
Average Receivables
Revenue Per Share
Interest Debt Per Share
Debt To Assets
Enterprise Value Over E B I T D A
Short Term Coverage Ratios
Price Earnings Ratio
Price Book Value Ratio
Price Earnings To Growth Ratio
Days Of Payables Outstanding
Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio
Pretax Profit Margin
Ebt Per Ebit
Operating Profit Margin
Effective Tax Rate
Company Equity Multiplier
Long Term Debt To Capitalization
Total Debt To Capitalization
Return On Capital Employed
Debt Equity Ratio
Ebit Per Revenue
Quick Ratio
Dividend Paid And Capex Coverage Ratio
Net Income Per E B T
Cash Ratio
Operating Cash Flow Sales Ratio
Days Of Inventory Outstanding
Days Of Sales Outstanding
Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios
Price To Book Ratio
Fixed Asset Turnover
Capital Expenditure Coverage Ratio
Price Cash Flow Ratio
Enterprise Value Multiple
Debt Ratio
Cash Flow To Debt Ratio
Price Sales Ratio
Return On Assets
Asset Turnover
Net Profit Margin
Gross Profit Margin
Price Fair Value
Return On Equity
Operating Cycle
Cash Conversion Cycle
Change In Cash
Free Cash Flow
Change In Working Capital
Begin Period Cash Flow
Other Cashflows From Financing Activities
Depreciation
Other Non Cash Items
Capital Expenditures
Total Cash From Operating Activities
Net Income
Total Cash From Financing Activities
End Period Cash Flow
Stock Based Compensation
Change To Inventory
Change To Account Receivables
Sale Purchase Of Stock
Total Cashflows From Investing Activities
Dividends Paid
Investments
Net Borrowings
Change To Operating Activities
Issuance Of Capital Stock
Change To Netincome
Change To Liabilities
Total Assets
Total Current Liabilities
Total Stockholder Equity
Property Plant And Equipment Net
Net Debt
Retained Earnings
Accounts Payable
Cash
Non Current Assets Total
Cash And Short Term Investments
Common Stock Shares Outstanding
Liabilities And Stockholders Equity
Non Current Liabilities Total
Other Stockholder Equity
Total Liab
Total Current Assets
Accumulated Other Comprehensive Income
Intangible Assets
Common Stock
Short Long Term Debt Total
Other Current Liab
Short Term Debt
Other Current Assets
Non Currrent Assets Other
Net Receivables
Inventory
Current Deferred Revenue
Other Assets
Capital Surpluse
Cash And Equivalents
Property Plant Equipment
Net Tangible Assets
Net Invested Capital
Short Long Term Debt
Capital Stock
Net Working Capital
Capital Lease Obligations
Property Plant And Equipment Gross
Depreciation And Amortization
Other Operating Expenses
Operating Income
Ebit
Research Development
Ebitda
Total Operating Expenses
Income Tax Expense
Interest Expense
Total Revenue
Gross Profit
Cost Of Revenue
Income Before Tax
Total Other Income Expense Net
Interest Income
Selling General Administrative
Net Income Applicable To Common Shares
Net Interest Income
Net Income From Continuing Ops
Reconciled Depreciation
Selling And Marketing Expenses
Probability Of Bankruptcy
Understanding current and past Know Labs Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Know Labs' financial statements are interrelated, with each one affecting the others. For example, an increase in Know Labs' assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Know Labs' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Know Labs. Check Know Labs' Beneish M Score to see the likelihood of Know Labs' management manipulating its earnings.
Know Labs Stock Summary
Know Labs competes with Nanalysis Scientific, Genasys, Kraken Robotics, Mind Technology, and Spectris Plc. Know Labs, Inc. focuses on the development and commercialization of proprietary technologies in the United States. Know Labs, Inc. was founded in 1998 and is headquartered in Seattle, Washington. Know Labs operates under Scientific Technical Instruments classification in the United States and is traded on AMEX Exchange. It employs 15 people.
Specialization
Information Technology, Scientific & Technical Instruments
The reason investors look at the income statement is to determine what Know Labs' earnings per share (EPS) will be in order to see if they want to buy more shares or not. For example, if a company earned $20 million in the last quarter and has 100,000 shares outstanding, its EPS is 20 cents. If you find that this number beats analysts' forecasts or is higher than it was from the same period last year, then you might want to buy more of this stock even though its price per share may not have changed.
Comparative valuation techniques use various fundamental indicators to help in determining Know Labs's current stock value. Our valuation model uses many indicators to compare Know Labs value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Know Labs competition to find correlations between indicators driving Know Labs's intrinsic value. More Info.
Know Labs is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers . At this time, Know Labs' Return On Equity is fairly stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Know Labs by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.
Know Labs Systematic Risk
Know Labs' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Know Labs volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty with a total number of output elements of thirty-one. The Beta measures systematic risk based on how returns on Know Labs correlated with the market. If Beta is less than 0 Know Labs generally moves in the opposite direction as compared to the market. If Know Labs Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Know Labs is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Know Labs is generally in the same direction as the market. If Beta > 1 Know Labs moves generally in the same direction as, but more than the movement of the benchmark.
Know Labs Thematic Clasifications
Know Labs is part of Measuring and Control Equipment investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. USA Equities from Measuring and Control Equipment industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions
This theme covers USA Equities from Measuring and Control Equipment industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions. Get More Thematic Ideas
Today, most investors in Know Labs Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Know Labs' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Know Labs growth as a starting point in their analysis.
Along with financial statement analysis, the daily predictive indicators of Know Labs help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Know Labs. We use our internally-developed statistical techniques to arrive at the intrinsic value of Know Labs based on widely used predictive technical indicators. In general, we focus on analyzing Know Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Know Labs's daily price indicators and compare them against related drivers.
When running Know Labs' price analysis, check to measure Know Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Know Labs is operating at the current time. Most of Know Labs' value examination focuses on studying past and present price action to predict the probability of Know Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Know Labs' price. Additionally, you may evaluate how the addition of Know Labs to your portfolios can decrease your overall portfolio volatility.